73 related articles for article (PubMed ID: 11117554)
1. Therapeutic benefit of polyamine-modified catalase as a scavenger of hydrogen peroxide and nitric oxide in familial amyotrophic lateral sclerosis transgenics.
Poduslo JF; Whelan SL; Curran GL; Wengenack TM
Ann Neurol; 2000 Dec; 48(6):943-7. PubMed ID: 11117554
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Reinholz MM; Merkle CM; Poduslo JF
Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
[TBL] [Abstract][Full Text] [Related]
3. Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis.
Przedborski S; Donaldson D; Jakowec M; Kish SJ; Guttman M; Rosoklija G; Hays AP
Ann Neurol; 1996 Feb; 39(2):158-65. PubMed ID: 8967746
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic benefits of intrathecal protein therapy in a mouse model of amyotrophic lateral sclerosis.
Ohta Y; Kamiya T; Nagai M; Nagata T; Morimoto N; Miyazaki K; Murakami T; Kurata T; Takehisa Y; Ikeda Y; Asoh S; Ohta S; Abe K
J Neurosci Res; 2008 Oct; 86(13):3028-37. PubMed ID: 18543336
[TBL] [Abstract][Full Text] [Related]
5. Benefit of tianeptine and morphine in a transgenic model of familial amyotrophic lateral sclerosis.
Chritin M; Savasta M; Besson G
Amyotroph Lateral Scler; 2006 Mar; 7(1):32-7. PubMed ID: 16546757
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen peroxide damages the zinc-binding site of zinc-deficient Cu,Zn superoxide dismutase.
Sampson JB; Beckman JS
Arch Biochem Biophys; 2001 Aug; 392(1):8-13. PubMed ID: 11469788
[TBL] [Abstract][Full Text] [Related]
7. The antioxidant N-acetylcysteine does not delay disease onset and death in a transgenic mouse model of amyotrophic lateral sclerosis.
Jaarsma D; Guchelaar HJ; Haasdijk E; de Jong JM; Holstege JC
Ann Neurol; 1998 Aug; 44(2):293. PubMed ID: 9708560
[No Abstract] [Full Text] [Related]
8. Mutation of superoxide dismutase elevates reactive species: comparison of nitration and oxidation of proteins in different brain regions of transgenic mice with amyotrophic lateral sclerosis.
Liu D; Bao F; Wen J; Liu J
Neuroscience; 2007 Apr; 146(1):255-64. PubMed ID: 17368952
[TBL] [Abstract][Full Text] [Related]
9. Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice.
Turner BJ; Rembach A; Spark R; Lopes EC; Cheema SS
J Neurosci Res; 2003 Nov; 74(4):605-13. PubMed ID: 14598305
[TBL] [Abstract][Full Text] [Related]
10. Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis.
Sala G; Beretta S; Ceresa C; Mattavelli L; Zoia C; Tremolizzo L; Ferri A; Carrì MT; Ferrarese C
Neurochem Int; 2005 Feb; 46(3):227-34. PubMed ID: 15670639
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and a murine superoxide dismutase-1 mutation promoting amyotrophic lateral sclerosis alter neurosecretion in the hypothalamo-neurohypophyseal axis.
Lutz-Bucher B; González de Aguilar JL; René F; Sée V; Gordon JW; Loeffler J
Neuroendocrinology; 1999 May; 69(5):377-84. PubMed ID: 10343179
[TBL] [Abstract][Full Text] [Related]
12. Plasma pharmacokinetics, nervous system biodistribution and biostability, and spinal cord permeability at the blood-brain barrier of putrescine-modified catalase in the adult rat.
Reinholz MM; Haggard JJ; Curran GL; Poduslo JF
Exp Neurol; 1999 Sep; 159(1):191-203. PubMed ID: 10486187
[TBL] [Abstract][Full Text] [Related]
13. Modulation of catalase peroxidatic and catalatic activity by nitric oxide.
Brunelli L; Yermilov V; Beckman JS
Free Radic Biol Med; 2001 Apr; 30(7):709-14. PubMed ID: 11275470
[TBL] [Abstract][Full Text] [Related]
14. Catalase as a roving scavenger of hydrogen peroxide: a hypothesis.
Yasmineh WG; Theologides A
J Lab Clin Med; 1993 Jul; 122(1):110-4. PubMed ID: 8320485
[No Abstract] [Full Text] [Related]
15. Putrescine-modified catalase with preserved enzymatic activity exhibits increased permeability at the blood-nerve and blood-brain barriers.
Wengenack TM; Curran GL; Olson EE; Poduslo JF
Brain Res; 1997 Aug; 767(1):128-35. PubMed ID: 9365024
[TBL] [Abstract][Full Text] [Related]
16. Lyophilized red wine administration prolongs survival in an animal model of amyotrophic lateral sclerosis.
Esposito E; Rossi C; Amodio R; Di Castelnuovo A; Bendotti C; Rotondo T; Algeri S; Rotilio D
Ann Neurol; 2000 Oct; 48(4):686-7. PubMed ID: 11026458
[No Abstract] [Full Text] [Related]
17. Familial amyotrophic lateral sclerosis.
Poser CM; Johnson M; Bunch LD
Dis Nerv Syst; 1965 Nov; 26(11):697-702. PubMed ID: 5843014
[No Abstract] [Full Text] [Related]
18. [Therapy of amyotrophic lateral sclerosis].
Hartmann-von Monakow K
Bibl Psychiatr Neurol; 1969; 139():475. PubMed ID: 5406914
[No Abstract] [Full Text] [Related]
19. Naloxone of no benefit in amyotrophic lateral sclerosis.
Silani V; Perini M; Fayoumi ZM; Scarlato G
Ann Neurol; 1983 Feb; 13(2):222. PubMed ID: 6830194
[No Abstract] [Full Text] [Related]
20. Studies on the development of catalase activity and the role of catalase in biological systems.
Kovács E; Mazarean HH
Acta Biol Acad Sci Hung; 1967; 18(3):261-9. PubMed ID: 5600535
[No Abstract] [Full Text] [Related]
[Next] [New Search]
